Skip to main content
C

Charmacy Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 2289 HKEX Wholesale and retail trade
Open in API
Filings indexed 509 across all filing types
Latest filing 2025-03-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2289

About Charmacy Pharmaceutical Co., Ltd.

http://www.chmyy.com

Charmacy Pharmaceutical Co., Ltd. is a leading pharmaceutical distribution company operating primarily in Southern China (Guangdong, Fujian, Guangxi, and Hainan). The core business involves distributing a comprehensive range of products, including Western medicines, Chinese patent medicines, and healthcare products, primarily targeting downstream distributors and retail terminal customers (chemists). The company specializes in the non-tender pharmaceutical market, where it holds a leading position. Additionally, Charmacy provides value-added services such as third-party logistics (3PL) and pharmaceutical product consultation, supported by modern distribution centers in key cities like Shantou, Guangzhou, and Shenzhen.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings Classification · 1% confidence The document is a standard monthly return (Form FF301) filed with the Hong Kong Exchange under Chapter 19B of the Listing Rules, reporting movements in share capital and securities for the month ended 28 February 2025. It is a routine compliance submission rather than a standalone financial report, earnings release, capital issuance notice, or AGM material. It does not fit any more specific category (e.g., share issue, buyback, dividend notice, or management change). Therefore it is best classified under the fallback category for general regulatory announcements: Regulatory Filings (RNS).
2025-03-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
Regulatory Filings Classification · 1% confidence The document is a monthly return submission to the Hong Kong Stock Exchange detailing movements (or lack thereof) in authorised, issued, and treasury shares under Chapter 19B of the Listing Rules. It is neither an AGM presentation, earnings release, nor a detailed financial report, nor is it announcing a dividend, capital change, or share transaction (no changes occurred). It is a periodic regulatory filing with no specific category in our taxonomy, making “Regulatory Filings (RNS)” the appropriate fallback.
2025-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
Regulatory Filings Classification · 1% confidence The document is a standard HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” showing movements in authorized share capital, issued shares, and treasury shares for the month ended 31 December 2024, submitted to Hong Kong Exchanges and Clearing Limited under Listing Rule requirements. It is a routine periodic filing to meet regulatory disclosure obligations rather than a financial report, dividend notice, share issue announcement, or presentation. Therefore, it does not fit specialized categories such as share issue (SHA) or transaction in own shares (POS), and should be classified as a general regulatory filing (RNS).
2025-01-02 English
POLL RESULTS OF THE 2024 SECOND EXTRAORDINARY GENERAL MEETING HELD ON 27 DECEMBER 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the poll (voting) results from the company’s 2024 Second Extraordinary General Meeting (EGM). It details resolutions proposed, vote counts (for, against, abstain) and confirms that the resolutions were duly passed by shareholders. This falls squarely under Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-12-27 English
RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE PROCUREMENT AND SALES TRANSACTIONS
Regulatory Filings Classification · 1% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2024-12-09 English
FORM OF PROXY FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 DECEMBER 2024 OR AT ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a “Form of Proxy” for an extraordinary general meeting, providing shareholders with the voting form and instructions. This is part of materials sent to shareholders to solicit their votes (proxy solicitation) rather than the meeting minutes or results. Therefore it falls under Proxy Solicitation & Information Statement (PSI).
2024-12-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.